NCT04683627 - A 12-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Osteoarthritis Pain of the Knee | Biotech Hunter

Enrollment

370

Participants

Timeline

Start Date

December 29, 2020

Primary Completion Date

July 18, 2022

Study Completion Date

July 25, 2022

Conditions

Osteoarthritis Pain of the Knee

Interventions

DRUG

Diclofenac sodium active topical patch

A topical patch with diclofenac sodium as active ingredient was used and evaluated for the treatment of OA pain of the knee.

DRUG

Placebo patch

A placebo patch without diclofenac sodium was used for the placebo arm.

Trial Locations (10)

Palmetto Clinical Research, Summerville

Universal Axon Clinical Research, LLC, Doral

Clinical Research of West Florida,Inc., Clearwater

Velocity Clinical Research, Cincinnati

The Arthritis and Diabetes Clinic, Inc., Monroe

Applied Research Center of Arkansas, Little Rock

Metroplex Clinical Research Center, Dallas

Quality Research Inc., San Antonio

Noven Pharmaceuticals, Inc., Jersey City

Partners in Clinical Research, Cumberland